|||**IMPACT SIERRA LEONE**|**IMPACT SIERRA LEONE**|**IMPACT SIERRA LEONE**|**IMPACT SIERRA LEONE**|||**1174397**|**1174397**||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**Receipts andpayments accounts**|||||||||**CC16a**||
|**For the period**<br>**from**<br>~~ee~~|||||01/01/2024<br>Period start date<br>~~ee~~||**To**||31/12/2024<br>Period end date||||
|**Section A Receipts and payments**|||||||||||||
|||**Unrestricted**<br>**funds**|**Unrestricted**||**Restricted**<br>**funds**||**Endowment**<br>**funds**||**Total funds**||**Last year**||
|||**to the nearest      £**|**to the nearest      £**|**to the nearest      £**|**to the nearest £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||||||
|||**-**|**-**||**-**||**-**||**-**||**600**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for_|_(Gross income for_||||||||||||
|_AR)_|_AR)_|**-**|**-**||**-**||**-**||**-**||**600**||
|**A2 Asset and investment sales,**<br>**(see table).**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~**_Sub total_**~~**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total receipts_                            -**<br>**-**<br>**-**<br>**-**<br>**600**<br>~~SS555~~|||||||||||||
|**A3 Payments**|||||||||||||
|||**-**|**-**||**-**||**-**||**-**||**600**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|||**-**|**-**||**-**||**-**||**-**||**-**||
|**_Sub total_ **||**-**|**-**||**-**||**-**||**-**||**600**||
|**A4 Asset and investment**<br>**purchases, (see table)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total payments_**<br>**-**<br>**-**<br>**-**<br>**-**<br>**600**<br>**_Net of receipts/(payments)_**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**A5 Transfers between funds**<br>**-**<br>**-                            -**<br>**-**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**-                            -**<br>**-**<br>**-**<br>**_Cash funds this year end_**<br>**-**<br>**-**<br>**-                            -**<br>**-**<br>~~SS55=~~<br>~~===~~<br>~~>=>=~~|||||||||||||



CCXX R1 accounts (SS) 

27/10/2025 

1 



||**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~_—-===~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~_—-===~~|
|---|---|---|
|||(agree balances with receipts and payments|
|||OK<br>OK<br>OK<br>account(s))|
|||**Unrestricted**<br>**Restricted**<br>**Endowment**|
|||**funds**<br>**funds**<br>**funds**|
|||**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**Details**|
||**B2 Other monetary assets**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~——==—~~|
||**B3 Investment assets**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Details**<br>~~att~~|
||**B4 Assets retained for the**<br>**charity’s own use**|**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Details**<br>~~att~~|
|||**Fund to which**<br>**Amount due**<br>**When due**|
|CCXX R2 accounts (SS)|Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>CCXX R2 accounts (SS)|**liability relates**<br>**(optional)**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Date of<br>approval<br>27.10.2025<br>Print Name<br>LAURETTA FODAY<br>Signature<br>**Details**<br>2<br>27/10/2025<br>~~——~~|



27/10/2025 

